MedPath

Ayurvedic therapy in management of sweta pardara (leucorrhea)

Phase 2
Not yet recruiting
Conditions
Health Condition 1: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere
Registration Number
CTRI/2022/07/043806
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Married women aged between 20 years to 45 years

2.Patient agrees to use condom/ abstinence during the treatment period.

3.Patient agrees to refrain from use of douches, oral or intra-vaginal antibiotics or antifungal agents or lubricants during the entire study period.

4.Presence of 3 out of 4 Amselââ?¬•s diagnostic criteria for bacterial vaginosis:

5.Off white (milky or gray), thin, homogeneous, adherent vaginal discharge, with minimal or absent pruritus.

6.Vaginal ph > 4.5

7.Positive ââ?¬Å?whifftestââ?¬? (fishy odor of the vaginal discharge with the addition of a drop of 10% koh).

8.Presence of clue cells � 20% of the total epithelial cells on microscopic examination of the saline wet mount.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Amsel�s diagnostic criteria for Bacterial vaginosisTimepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
1. Normal Gram Stained Vaginal smear. <br/ ><br>2. Scoring patterns <br/ ><br>vaginal discharge(Verbal rating scale) <br/ ><br>Low back ache(Visual analogue scale) <br/ ><br>Dyspareunia(Verbal Rating Scale) <br/ ><br>Vaginal Itching(Verbal Rating Scale) <br/ ><br>Malodor (Verbal Rating Scale) <br/ ><br>3. Improvement in Quality of life assess by SF 36 questionnaires.Timepoint: 30 days
© Copyright 2025. All Rights Reserved by MedPath